INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

71,097 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
TC
Thornton Joseph ClayChief Financial Officer
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Grant or award
A—
328.9K sh
Nov 4, 2026
Page 31 of 1778
← PrevNext →
Nov 6, 2026
traded Nov 4, 2026
+2d
SEC Form 4

Evidence

13
BR
Brooks Judson RyanSVP and General Counsel
ROADConstruction Partners, Inc.
Grant or award
A—
1,876 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

13
BR
Brooks Judson RyanSVP and General Counsel
ROADConstruction Partners, Inc.
Grant or award
A—
3,824 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

13
BG
Baugnon Robert GSenior VP, Personnel and Admin
ROADConstruction Partners, Inc.
Grant or award
A—
1,876 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

13
LA
Lin AlfredDirector
DASHDoorDash, Inc.
Other acquisition or disposition
J—
381.6K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

13
LV
Leff Daniel VDirector
FUBOFuboTV Inc.
Option exercise
M—
2,410 sh
Nov 6, 2026Nov 6, 2026
traded Nov 6, 2026
+0dSEC Form 4

Evidence

13
DA
Durham Karilee ASVP, Human Resources
SWKSSKYWORKS SOLUTIONS, INC.
Option exercise
M—
2,935 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

13
BI
Burton IngridDirector
EXTREXTREME NETWORKS INC
Option exercise
M—
11.8K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

13
HM
Holmgren Kathleen MDirector
EXTREXTREME NETWORKS INC
Option exercise
M—
11.8K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

13
KR
Khanna RajDirector
EXTREXTREME NETWORKS INC
Option exercise
M—
11.8K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

13
CD
Carroll DonnaDirector
BGSFBGSF, INC.
Grant or award
A—
4,771 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

13
BL
Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER
EDITEditas Medicine, Inc.
Grant or award
A—
16.5K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

13
RE
Robinson ElliottDirector
HNGEHinge Health, Inc.
Open-market sale
SELL—
0 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

13
MM
McIsaac MartinaPresident & CEO
MSMMSC INDUSTRIAL DIRECT CO INC
Option exercise
M—
1,397 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

13
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$182K
310 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

13
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$70K
120 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

13
SI
Snow John Ingalls IIIDirector
WSBKWinchester Bancorp, Inc./MD/
Grant or award
A$41K
3,000 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

13
DL
Davis Stephen LDirector
NANAInland Real Estate Income Trust, Inc.
Grant or award
A—
2,368 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

13
HG
Henry GwenDirector
NANAInland Real Estate Income Trust, Inc.
Grant or award
A—
2,368 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

13
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$186K
320 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

13
KO
Koren OferCFO
GLBEGlobal-E Online Ltd.
Option exercise
M—
12.5K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

13
FI
Figueras IgnacioDirector
FUBOFuboTV Inc.
Option exercise
M—
2,410 sh
Nov 6, 2026Nov 6, 2026
traded Nov 6, 2026
+0dSEC Form 4

Evidence

13
PK
Patel Sanj KDirector, CHAIRMAN & CEO
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$135K
1,460 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

13
CR
Corbin Charles R. Jr.See Remarks
HGVHilton Grand Vacations Inc.
Option exercise · 10b5-1 plan
M$754K
22.6K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

13
SF
Shimanovsky Boris F.EVP, Chief Technology Officer
ZIPZIPRECRUITER, INC.
Open-market sale · 10b5-1 plan
SELL$141K
30.0K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

13
RE
Robinson ElliottDirector
HNGEHinge Health, Inc.
Open-market sale
SELL—
0 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

12
NZ
Nowaid ZabiGeneral Counsel
MARAMARA Holdings, Inc.
Tax withholding
F$89K
13.9K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

12
MF
Mahoney Michael FDirector, Chairman, President & CEO
BSXBOSTON SCIENTIFIC CORP
Gift
G—
150.0K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

12
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M$445K
905 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

12
PD
Perlman DanaDirector
ORLYO REILLY AUTOMOTIVE INC
Gift
G$25K
275 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

12
FR
Foster Dale RichardDirector, Chief Executive Officer
CLMBClimb Global Solutions, Inc.
Tax withholding
F$54K
1,262 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

12
DR
Defrancesco Salvatore R JrTreasurer & CFO
FDBCFIDELITY D & D BANCORP INC
Derivative conversion
C$114K
1,625 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

12
MS
Mitra SabyaschiGroup President
EMREMERSON ELECTRIC CO
Tax withholding
F$82K
492 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

12
PL
Preston Michael L.EVP, Chf Strategy Officer & GC
CRCCalifornia Resources Corp
Tax withholding
F$124K
2,571 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

12
GD
Gould Christopher D.EVP & Chief Sustainability Off
CRCCalifornia Resources Corp
Tax withholding
F$58K
1,203 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

12
DP
DIRK VAN DE PUTDirector, Chief Executive Officer
MDLZMondelez International, Inc.
Option exercise · 10b5-1 plan
M$4.72M
108.4K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

12
SI
Sudnow Howard IanDirector
SUNSSunrise Realty Trust, Inc.
Other acquisition or disposition
J—
1,500 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

12
RD
Rollins James D IiiDirector
HBANHUNTINGTON BANCSHARES INC /MD/
Gift
G—
5,000 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

12
CA
Curtis Geoffrey AdamsDirector
WSBKWinchester Bancorp, Inc./MD/
Grant or award
A$102K
7,500 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

12
MJ
Merritt Edward JDirector
WSBKWinchester Bancorp, Inc./MD/
Grant or award
A$102K
7,500 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence